• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

起源——古代美索不达米亚文化中的肾脏与肾脏病学

Beginnings-The Kidney and Nephrology in Ancient Mesopotamian Culture.

作者信息

Eknoyan Garabed

机构信息

The Selzman Institute of Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

出版信息

Semin Dial. 2016 May;29(3):236-46. doi: 10.1111/sdi.12441. Epub 2015 Oct 1.

DOI:10.1111/sdi.12441
PMID:26424002
Abstract

A defining period in the history of civilization occurred in ancient Mesopotamia. While some of Mesopotamian contributions to knowledge (writing, mathematics, astronomy) have been recognized, those made to medicine are just beginning to be studied and appreciated. The medicine of the time developed in a theocratic society where local gods controlled all aspects of life and their healers were learned scribes who established the priestly medicine of old. For their use of prayers and incantations as a component of therapy Mesopotamian medicine has been belittled and relegated to magic. In fact, the Mesopotamian healers established the basic medical skills of observation, diagnosis, prognosis and treatment and, over time, systematically produced an expanding corpus of medical knowledge that had not existed theretofore. The kidney as an organ, the components of the urogenital tract, some signs and symptoms of renal diseases, and the art of urinalysis were first conceptualized, studied, and codified in Mesopotamia. In doing so, the Mesopotamians set the foundations of rational medicine that would follow after the introduction of the phonetic alphabet and the Socratic method of questioning and debate to stimulate critical analysis.

摘要

文明史上一个具有决定性意义的时期出现在古代美索不达米亚。虽然美索不达米亚对知识(书写、数学、天文学)的一些贡献已得到认可,但其对医学的贡献才刚刚开始被研究和重视。当时的医学是在一个神权社会中发展起来的,当地的神灵掌控着生活的方方面面,他们的治疗师是有学问的抄写员,创立了古老的祭司医学。由于美索不达米亚医学将祈祷和咒语作为治疗的一部分,它一直被贬低并被归入魔法范畴。事实上,美索不达米亚的治疗师建立了观察、诊断、预后和治疗等基本医疗技能,并且随着时间的推移,系统地积累了越来越多此前不存在的医学知识。肾脏作为一个器官、泌尿生殖道的组成部分、肾脏疾病的一些体征和症状以及尿液分析技术,都是在美索不达米亚首先被概念化、研究并编纂的。通过这样做,美索不达米亚人为理性医学奠定了基础,而这种理性医学是在引入拼音字母表以及苏格拉底式的提问和辩论方法以激发批判性分析之后才得以发展的。

相似文献

1
Beginnings-The Kidney and Nephrology in Ancient Mesopotamian Culture.起源——古代美索不达米亚文化中的肾脏与肾脏病学
Semin Dial. 2016 May;29(3):236-46. doi: 10.1111/sdi.12441. Epub 2015 Oct 1.
2
Mesopotamian medicine.美索不达米亚医学。
S Afr Med J. 2007 Jan;97(1):27-30.
3
Stroke in Ancient Mesopotamia.古代美索不达米亚的中风
Med Arch. 2018 Dec;72(6):449-452. doi: 10.5455/medarh.2018.72.449-452.
4
Tamil merchant in ancient Mesopotamia.古代美索不达米亚的泰米尔商人。
PLoS One. 2014 Oct 9;9(10):e109331. doi: 10.1371/journal.pone.0109331. eCollection 2014.
5
The future of the realm: medicine and divination in ancient Syro-Mesopotamia.该领域的未来:古代叙利亚 - 美索不达米亚的医学与占卜
Am J Nephrol. 1999;19(2):133-9. doi: 10.1159/000013439.
6
[Medicine in ancient Mesopotamia--part 1].[古代美索不达米亚的医学——第一部分]
Acta Med Port. 2009 Nov-Dec;22(6):841-54. Epub 2010 Jan 10.
7
The Beginnings of Drug Therapy: Ancient Mesopotamian Medicine.
Drug News Perspect. 2002 Apr;15(3):187-192. doi: 10.1358/dnp.2002.15.3.840015.
8
Ancient surgeons: A characterization of Mesopotamian surgical practices.古代外科医生:美索不达米亚外科实践的特征。
Am J Surg. 2022 Aug;224(2):790-793. doi: 10.1016/j.amjsurg.2022.03.047. Epub 2022 Apr 1.
9
Chapter 2: mesopotamia.第二章:美索不达米亚。
Handb Clin Neurol. 2010;95:15-27. doi: 10.1016/S0072-9752(08)02102-7.
10
Sāmānu as a Human Disease.
J Med Cuneif. 2016 Sep(26):33-46.

引用本文的文献

1
A 5000-year overview of the history of pain through ancient civilizations to modern pain theories.从古代文明到现代疼痛理论的5000年疼痛史概述。
Pain Rep. 2025 Apr 3;10(3):e1241. doi: 10.1097/PR9.0000000000001241. eCollection 2025 Jun.
2
Medical Records: A Historical Narrative.《病历:一段历史叙事》
Biomedicines. 2022 Oct 17;10(10):2594. doi: 10.3390/biomedicines10102594.